Caffeine
Caffeine is the world's most widely used stimulant; it is safe for most adults in moderate amounts but can cause dependence, and pure or highly concentrated caffeine powders can be fatal.
Overview
Caffeine is a mild central nervous system stimulant and the most widely used psychoactive substance in the world. It occurs naturally in coffee, tea, cacao, and some other plants, and is added to soft drinks, energy drinks, and a range of over-the-counter medications, where it can help relieve drowsiness or boost the effect of some pain relievers. The U.S. Food and Drug Administration treats caffeine as both a drug and a food additive. For most healthy adults, the FDA points to about 400 milligrams a day — roughly two to three cups of coffee — as an amount not generally associated with harmful effects, though sensitivity varies and the figure is lower for pregnant people and not appropriate for children.
Source: FDA; MedlinePlus
Chemistry & mechanism of action
Caffeine works mainly by blocking adenosine, a brain chemical that builds up during the day and promotes drowsiness. By occupying adenosine receptors, caffeine prevents that 'slow down' signal, which leaves excitatory neurotransmitters more active and produces increased alertness and reduced fatigue. This also prompts the release of adrenaline, which contributes to caffeine's stimulant effects on the heart and circulation. With regular use the brain adapts, which is why tolerance develops and why stopping abruptly can produce withdrawal.
Source: MedlinePlus; peer-reviewed pharmacology literature
Effects
In typical amounts, caffeine increases alertness and reduces the feeling of fatigue, and can improve concentration. Higher doses can cause jitteriness, anxiety, restlessness, a faster or pounding heartbeat, upset stomach, and difficulty sleeping. Because caffeine has a real physical dependence profile, regular users who stop suddenly can experience withdrawal — most commonly headache, fatigue, low mood, irritability, and difficulty concentrating — usually within a day or so of stopping.
Source: MedlinePlus; FDA
Risks & harms
For most healthy adults, moderate caffeine intake is considered safe. The serious danger is dose. Symptoms of caffeine overdose include a rapid or erratic heartbeat, seizures, vomiting, diarrhea, disorientation, and in severe cases death. The greatest risk comes from pure or highly concentrated caffeine sold as bulk powder or liquid: the FDA has warned consumers to avoid these products and has linked them to deaths in otherwise healthy people, because a single teaspoon of pure powdered caffeine can equal the caffeine in roughly 28 cups of coffee, and the difference between an active and a lethal amount is too small to measure safely with kitchen tools. Caffeine can also be risky for people with certain heart conditions, for pregnant people, and when combined with alcohol or other stimulants. If a caffeine overdose is suspected, contact Poison Control at 1-800-222-1222, or call 911 in an emergency.
Source: FDA; MedlinePlus
Legal status (US)
Caffeine is legal and unscheduled in the United States. The FDA regulates it as both a food additive and, in some products, a drug, and it is generally recognized as safe in cola-type beverages within set limits. Pure and highly concentrated caffeine products sold directly to consumers in bulk have been the subject of FDA warnings and enforcement, because they are considered dangerous; the agency has acted against such products under food-safety law. Caffeine in ordinary foods, beverages, and over-the-counter medicines is freely available. This is general legal information, not legal advice.
Source: FDA
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling, because penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass, most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating, move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst, but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing, long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With stimulants, overheating and a racing heart are the main concerns, get somewhere cool, stop any physical activity, and don't take more.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft, not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown, pending review”Identity
- PubChem CID
- 2519PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- 1,3,7-trimethylpurine-2,6-dionePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C8H10N4O2PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CN1C=NC2=C1C(=O)N(C(=O)N2C)CPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- RYYVLZVUVIJVGH-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- Guaranine, 1,3,7-Trimethylxanthine, Methyltheobromine, Theine, Thein, Cafeina, Caffein, Cafipel, Koffein, MateinaPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- HUMAN OTC DRUGopenFDA drug label ↗ · retrieved 2026-06-18
- Shape
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Color
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Imprint
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Score
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown, pending review
Effects, risks & interactions
- Effects
- Caffeine is the world's most widely used psychoactive drug — a mild stimulant that works by blocking adenosine receptors, which reduces the sense of tiredness. Found in coffee, tea, energy drinks and many sodas, it produces increased alertness, wakefulness and concentration and a mild lift in mood and energy. Its effects are modest and familiar, which is why it is generally treated as a benign everyday substance rather than a "drug."PubChem CID 2519 ↗ · retrieved 2026-06-18
- Risks
- In ordinary dietary amounts caffeine is low-risk for most people, but it is not risk-free. It commonly causes anxiety, jitteriness, a racing heart and disturbed sleep, and it can worsen certain heart-rhythm and anxiety conditions. Regular use produces mild dependence with a genuine withdrawal (headache, fatigue, low mood). The most serious danger comes from concentrated forms — pure caffeine powders and highly concentrated products — where the amount in a small measure can be many times a normal serving; caffeine overdose (severe agitation, dangerous heart rhythms, seizures) can be fatal, and these concentrated products have caused deaths.PubChem CID 2519 ↗ · retrieved 2026-06-18
- Interactions
- Unknown, pending review
Pill catalog
Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending reviewThis drug comes in 405different versions. Make sure you’re looking at the right one, use the search above to find your exact pill by imprint, color, or shape.
Showing 24 of 405 variants
- Strength
- ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Preferred Pharmaceuticals Inc.
- Schedule
- CIII
- NDC
- 68788-8137 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 250 mg/1; ASPIRIN 250 mg/1; CAFFEINE 65 mg/1
- Imprint
- S53
- Color
- white
- Shape
- CAPSULE
- Form
- TABLET
- Labeler
- Pioneer Life Sciences, LLC
- NDC
- 72090-007 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 500 mg/1; CAFFEINE 65 mg/1
- Imprint
- None
- Color
- red
- Shape
- CAPSULE
- Form
- TABLET
- Labeler
- Pioneer Life Sciences, LLC
- NDC
- 72090-004 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 250 mg/1; ASPIRIN 250 mg/1; CAFFEINE 65 mg/1
- Imprint
- 44 159
- Color
- white
- Shape
- ROUND
- Form
- TABLET, FILM COATED
- Labeler
- Chain Drug Marketing Association, Inc.
- NDC
- 83324-063 ↗ · 2026-06-18
- Strength
- CAFFEINE 200 mg/1
- Imprint
- 44 344
- Color
- white
- Shape
- OVAL
- Form
- TABLET, FILM COATED
- Labeler
- Better Living Brands, LLC
- NDC
- 21130-944 ↗ · 2026-06-18
- Strength
- CAFFEINE 200 mg/1
- Imprint
- TCL 343
- Color
- yellow
- Shape
- ROUND
- Form
- TABLET, FILM COATED
- Labeler
- Time Cap Labs, Inc
- NDC
- 49483-343 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 250 mg/1; ASPIRIN 250 mg/1; CAFFEINE 65 mg/1
- Imprint
- TCL 370
- Color
- white
- Shape
- CAPSULE
- Form
- TABLET, COATED
- Labeler
- Kroger Company
- NDC
- 41226-370 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1
- Imprint
- TCL 347
- Color
- white
- Shape
- CAPSULE
- Form
- TABLET, FILM COATED
- Labeler
- Time Cap Labs, Inc
- NDC
- 49483-347 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 250 mg/1; ASPIRIN 250 mg/1; CAFFEINE 65 mg/1
- Imprint
- 44 334
- Color
- white
- Shape
- OVAL
- Form
- TABLET, FILM COATED
- Labeler
- HART Health
- NDC
- 50332-0144 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 250 mg/1; ASPIRIN 250 mg/1; CAFFEINE 65 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Lil' Drug Store Products, Inc.
- NDC
- 66715-6338 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 250 mg/1; ASPIRIN 250 mg/1; CAFFEINE 65 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Lil' Drug Store Products, Inc.
- NDC
- 66715-5506 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1
- Imprint
- 44 390
- Color
- white
- Shape
- OVAL
- Form
- TABLET, FILM COATED
- Labeler
- WinCo Foods, LLC
- NDC
- 67091-334 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- REMEDYREPACK INC.
- Schedule
- CIII
- NDC
- 70518-4309 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Advanced Rx of Tennessee, LLC
- Schedule
- CIII
- NDC
- 80425-0570 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 250 mg/1; ASPIRIN 250 mg/1; CAFFEINE 65 mg/1
- Imprint
- 44 159
- Color
- white
- Shape
- ROUND
- Form
- TABLET, FILM COATED
- Labeler
- Rite Aid Corporation
- NDC
- 11822-1590 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Redpharm Drug
- Schedule
- CIII
- NDC
- 67296-2204 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1
- Imprint
- Unknown — pending review
- Color
- Unknown — pending review
- Shape
- Unknown — pending review
- Form
- TABLET
- Labeler
- Bryant Ranch Prepack
- Schedule
- CIII
- NDC
- 71335-2546 ↗ · 2026-06-18
- Strength
- CAFFEINE 200 mg/1
- Imprint
- 44 226
- Color
- yellow
- Shape
- ROUND
- Form
- TABLET
- Labeler
- Amerisource Bergen
- NDC
- 46122-457 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 300 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1
- Imprint
- Lannett 4095
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE
- Labeler
- Lannett Company, Inc.
- NDC
- 0527-4095 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 300 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1
- Imprint
- FIORICET
- Color
- blue
- Shape
- CAPSULE
- Form
- CAPSULE
- Labeler
- Actavis Pharma, Inc.
- NDC
- 52544-080 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1
- Imprint
- MIA 110
- Color
- white
- Shape
- OVAL
- Form
- TABLET
- Labeler
- Chartwell RX, LLC
- Schedule
- CIII
- NDC
- 62135-751 ↗ · 2026-06-18
- Strength
- CAFFEINE 200 mg/1
- Imprint
- LL64 57344
- Color
- yellow
- Shape
- ROUND
- Form
- TABLET
- Labeler
- PUBLIX SUPER MARKETS INC
- NDC
- 56062-030 ↗ · 2026-06-18
- Strength
- CAFFEINE 100 mg/1
- Imprint
- 100
- Color
- white
- Shape
- ROUND
- Form
- TABLET, COATED
- Labeler
- Bell Pharmaceuticals, Inc
- NDC
- 15579-201 ↗ · 2026-06-18
- Strength
- ACETAMINOPHEN 150 mg/1; CAFFEINE 12.5 mg/1
- Imprint
- JW
- Color
- brown
- Shape
- OVAL
- Form
- TABLET
- Labeler
- Lydia Co., Ltd.
- NDC
- 72988-0032 ↗ · 2026-06-18
Dosage
Pending medical reviewer
